Questions and Answers: Transparency and authorisation mechanism for exports of COVID-19 vaccines

(Mufid Majnun, Unsplash)

This article is brought to you in association with the European Commission.


What is the rationale for the measure?

The objective of this measure is to ensure timely access to COVID-19 vaccines for all EU citizens and to tackle the current lack of transparency of vaccine exports outside the EU.

The European Union has supported the rapid development and production of several vaccines against COVID-19 with a total of €2.7 billion and it is important to protect the integrity of this substantial investment from the EU budget.

The Commission is concerned by the lack of transparency around the ways some companies are operating and wants to have complete information in order to ensure they fulfil their contractual commitments.

It is not our intention to restrict exports any more than absolutely necessary, and the Union remains fully committed to international solidarity and its international obligations.

Scope

What is the nature of the measures the Commission has adopted?

To address this very serious and immediate public health issue, the Commission has adopted a temporary export transparency and export authorisation mechanism on the basis of Regulation 2015/479 on common rules for exports.

This is not an export ban. This measure would specifically target exports of COVID-19 vaccines covered by an Advance Purchase Agreement (APA) with the EU. These exports will be subject to an early notification and authorisation before they are effectively shipped outside the EU.

This measure applies from 30 January 2021 and runs until 31 March 2021.

A large number of exports will be exempted from the mechanism.

Does the Commission measure cover trade between the EU Member States?

An export authorisation foreseen in the Regulation is required for exports outside the Union market (whether or not originating in the Union).

Such authorisation shall be granted by the competent authorities of the Member State where the vaccines are manufactured and shall be issued in writing or by electronic means.

Which exports will be exempt?

Exports to Republic of Albania, Andorra, Bosnia and Herzegovina, the Faeroe Islands, the Republic of Iceland, Kosovo*, the Principality of Liechtenstein, Montenegro, the Kingdom of Norway, the Republic of North Macedonia, the Republic of San Marino, Serbia, the Swiss Confederation, Vatican City State, the overseas countries,  territories listed in Annex II of the Treaty of the Functioning of the European Union, and exports to Büsingen, Heligoland, Livigno, Ceuta and Melilla, Algeria, Egypt, Jordan, Lebanon, Libya, Morocco, Palestine*, Syria, Tunisia, Armenia, Azerbaijan, Belarus, Georgia, Israel, Moldova and Ukraine.

Exports to any of the 92 low and middle income countries in the COVAX Advance Market Commitment list.

Exports of COVID vaccines purchased and/or delivered through COVAX, UNICEF and PAHO with destination to any other COVAX participating country.

Exports of purchases by EU Member States under the EU Advance Purchase Agreements and redirected to a third country as a donation or resale.

Exports in the context of a humanitarian emergency response.

Exports to facilities located on the continental shelf of a Member State or the exclusive economic zone declared by a Member State pursuant to the United Nations Convention on the Law of the Sea.

Member States

Has a MS notified unilateral measures?

So far, only Belgium has notified an emergency measure.

We strongly discourage to take national measures.

With an EU-wide measure the EU will make sure that exports can actually continue when they are legitimate.

Third countries/Global dimension

What if a third country has an APA with a manufacturer in the EU?

The Commission is mindful of APAs contracted by third countries, and will endeavour to ensure that the expectations of these countries to obtain their deliveries will be met.

We call on companies with APAs to meet their obligations to deliver on their commitments.

Process

What happens now until 31 March 2021. Why is this limited to end of March? Isn’t the measure supposed to be valid only for 6 weeks?

Due to the urgency of the situation, justified by the lack of transparency in a time where the production and delivery of vaccines is still in the building-up phase and the ensuing temporary global shortage, the measure was adopted by the Commission using the emergency procedure.

This allows the Commission to act fast before the Member States are formally consulted.

The Regulation applies from 30 January 2021.

In accordance with the Regulation allowing us to adopt such emergency response, the measures cannot exceed six weeks (Article 5(5) of Regulation (EU) 2015/479).

However, the Commission intends to propose an extension of this measure until the end of March. Pursuant to Article 6 of that Regulation measures can be adopted after this period via comitology.

During the initial six-weeks period, the Member States will be consulted on the potential adaptations of the current measure and any potential future steps.

Has the Commission reacted at the request of the Member States. If yes, which ones? Did the Commission act on its own initiative?

Member States are part of the Steering Committee which discusses all decisions in the context of the negotiations with vaccine producers and their follow-up, including the possibility to include a transparency and authorisation mechanism in relation to the exports of vaccines.

Do MS have a discretion under the measure adopted by the Commission? How does the system work?

Member States are required to set up export authorisation regimes.

Companies request an export authorisation in the Member State where the vaccine is manufactured.

Member States will process applications for export authorisations as soon as possible and no later than two working days after receiving all the required information.

This period may be extended by a further two working days but only under exceptional circumstances and for duly justified reasons.

In deciding whether to grant an export authorisation under this Regulation, Member States, together with the Commission, shall assess whether the volume of exports is not such that it poses a threat to the execution of the Advance Purchase Agreements the EU has concluded with vaccine manufacturers.

Upon receiving the request, Member States immediately seek the agreement of the Commission.

In order to allow the relevant authorities to assess the request for export authorisation, vaccine producers subject to this Regulation are requested to provide relevant data on their exports since 29 October 2020 toghether with their first request for export authorisation.

Even after authorising an export, the competent Member State authorities can verify the information submitted by the exporter.

What if a company refuses to provide the retroactive data?

The absence of such information may lead to export authorisations being refused.

Will there be a publication of the actions? Who will publish these and where?

The Commission will regularly report on the authorisations granted and refused.

What type of proposal is the export authorisation scheme?

It’s an implementing act.

WTO

Is the regulation compatible with WTO and G20 commitments?

It is in line with all of the EU’s international obligations and commitments.

The EU strongly supports the principle that any measures deemed necessary to prevent or relieve critical shortages are implemented in a manner that is targeted, transparent, proportionate, temporary and consistent with WTO obligations.

The measure is also fully in line with what the EU has proposed in the context of the WTO trade and health initiative as it gives particular consideration to the interest of the least developed and developing countries with scarce manufacturing capacities and which are highly dependent on imports. The scheme also ensures that the operation of the COVAX facility is not impeded.

The EU will ensure transparency about this measure towards its trading partners at the WTO.

*This designation is without prejudice to positions on status, and is in line with UNSCR 1244/1999 and the ICJ Opinion on the Kosovo declaration of independence.    

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Coronavirus spread now a global emergency declares World Health Organization

The multidisciplinary team facing the multidrug resistant form of Tuberculosis in the state of Amazonas (Brazil)

Crimean crisis: not enough to slow down European indices

Europe to turn the Hamburg G20 Summit into a battlefield

This is how oil spills damage our environment

Young people are key to defusing unrest and restoring public trust

China and China-EU Relations in the New Era

Germany: A grand coalition may trouble employers and bankers

RescEU: MEPs vote to upgrade EU civil protection capacity

GSMA announces first speakers for Mobile 360 Series-Middle East and North Africa

Digital learning can help us close the global education gap. This is how

Palm Oil: With Malaysia cracking down on production, what’s the alternative?

The Sahel is engulfed by violence. Climate change, food insecurity and extremists are largely to blame

Mood changes in Europe in favour of growth and jobs

The EU condemns Faroe Islands and Iceland to poverty

UN ready to rise above political fray and help Venezuelans based ‘on need, and need alone’

Why we need artists who strive for social change

It’s a frenzied clash between moderates and no-deal Brexiteers

Most leaders are missing this crucial character trait

Mental health and suicide prevention – What can be done to increase access to mental health services in my region?

How to maintain mental health in times of pandemic

Coronavirus: Commission launches data sharing platform for researchers

Eurozone dignitaries play with people’s life savings

The community and a decent working conditions for the young health workforce

MEPs back plans to promote water reuse for agricultural irrigation

World Cancer Day: Here’s how perceptions about the disease differ around the world

Which green actions really reduce climate emissions?

Why are wildfires getting worse?

WhatsApp to face scrutiny from EU regulators task force over data sharing with Facebook

European Agenda on Migration: Still fragile situation gives no cause for complacency

Growing a future free of terrorism: UN News special report from Cameroon

Aviation Safety: Commission adopts new EU Air Safety List

European Semester: The Winter Package explained

Vestager vs. Google: a fight to ensure a competitive innovation framework

Is Eurozone heading for disinflation?

3 ways to disrupt education and help bridge the skills gap

Conflict and climate change challenge sustainable development effort: UN report

Number of members in Parliament’s committees to change after Brexit

Coronavirus: rescEU medical materials dispatched to Serbia

Biodiversity: MEPs demand binding targets to protect wildlife and humans

Here’s how sustainability can make you stand out from the crowd

Banks and businesses must step up and work together to fight climate change

Britain and Germany change attitude towards the European Union

Doctors without borders

World Mental Health Day is a chance to listen to those with the condition – the biggest experts of all

The relationship between Dengue and the rainfall in Boa Vista, Brazil

Pesticides: MEPs propose blueprint to improve EU approval procedure

Data will allow us to predict the future if we let it. Here’s how

How to future-proof India’s economy

France sneaks into the Geneva US-Iran talks to claim its business share in Tehran

The US + Britain trivialize mainland Europe, NATO and the EU

Impact of high debt levels on least developed countries ‘cannot be overstated’, says UN

99 per cent of intravenous drug users lack access to health, ‘social services with dignity’ says UNAIDS chief

Is Germany yielding to pressures for more relaxed economic policies?

Pervasive corruption costs $2.6 trillion; disproportionately affects ‘poor and vulnerable’ says UN chief

EU budget: Reinforcing Europe’s cultural and creative sectors

Humanitarian aid: EU mobilises €22 million to support most vulnerable in Iran and Pakistan

Happy workers are more productive, research shows

Denmark’s last circus elephants are retiring – here’s what might take their place

Coronavirus Global Response: EU Humanitarian Air Bridge supports Venezuela

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: